Jenburkt Pharmaceuticals (BOM:524731) EPS (Basic) : ₹72.65 (TTM As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Jenburkt Pharmaceuticals EPS (Basic)?

Jenburkt Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ₹19.35. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹72.65.

Jenburkt Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2025 was ₹19.35. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹72.65.

Jenburkt Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2025 was ₹19.35. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 72.65.

During the past 12 months, Jenburkt Pharmaceuticals's average EPS without NRIGrowth Rate was 23.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 14.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 17.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Jenburkt Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 67.20% per year. The lowest was -1.50% per year. And the median was 17.90% per year.

Jenburkt Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Jenburkt Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenburkt Pharmaceuticals EPS (Basic) Chart

Jenburkt Pharmaceuticals Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

EPS (Basic)

Get a 7-Day Free Trial

35.96

48.58

53.90

58.86

72.65

Jenburkt Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															17.86	16.80	21.75	14.75	19.35

Jenburkt Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Jenburkt Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(320.606	-	0)	/	4.413
	=	72.65

Jenburkt Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(85.366	-	0)	/	4.412
	=	19.35

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹72.65

Jenburkt Pharmaceuticals (BOM:524731) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Jenburkt Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Jenburkt Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jenburkt Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jenburkt Pharmaceuticals Ltd (BOM:524731) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

93, Jayprakash Road, Nirmala Apartments, Andheri (West), Mumbai, MH, IND, 400058

Website

https://www.jenburkt.com

Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.

Jenburkt Pharmaceuticals Headlines

No Headlines